Business Wire

WA-KYMETA

23.3.2021 14:02:14 CET | Business Wire | Press release

Share
Kymeta Interoperability with Kepler LEO Satellites Promises Powerful Connectivity of the Future with Kymeta™ u8 Terminal

Kymeta (www.kymetacorp.com ), the communications company making mobile global, and Kepler Communications (www.kepler.space ) announced today the successful demonstration of the Kymeta u8 Terminal with LEO satellite acquisition , tracking and throughput measurements, during extreme cold weather temperatures. The collaboration with Kepler supports Kymeta’s goal to develop solutions that are future proof with a clear LEO upgrade path and compatible with growing mega constellations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210323005226/en/

In 2020, Kepler was selected for an extended u8 beta trial to capture the extended Northern winter in Inuvik, Canada. Frequent revisit times from the Kepler LEO satellites combined with the local environment of unprotected cold weather, snow, and ice provided a unique testing opportunity for the latest Kymeta technology. Results have demonstrated a significant increase in performance with lower latency, enhanced look angles and speeds that are approaching 10X faster than earlier products with higher throughput and total data passed.

The u8 system is designed to work down to -40o C. During testing, Kymeta and Kepler were able to update software facilitating the testing of new algorithms in real time. Updates included capabilities of on-board FPGA-based tracking receivers, which allowed for usage of channels more than 2 times larger than previous demonstrations.

Testing results exceeded expectations during these cold weather trials with average uplink and downlink speeds of 100 Mbps, providing the ability to transfer more than two gigabytes of data with each pass. Initial testing was completed using linear polarization on the u8 – in a future software upgrade the addition of circular polarization support will lead to additional increases in data transfer speeds.

“Kepler has been a great trial partner because they are agile and able to make adjustments for optimized performance at the same time we are adjusting the u8 terminal,” said David Harrower, Senior Vice President of Global Sales at Kymeta. “Many of our customers are interested in compatibility with LEO satellite services, and this testing helps ensure the longevity of the u8 and Kymeta Connect as well as offer a solution that takes advantage of the increased utility of LEO satellites.”

"The performance of the Kymeta u8 with Kepler's Global Data Service has exceeded our expectations," said Wen Cheng Chong, Kepler's CTO and Co-Founder. "Our recent testing and development efforts demonstrated not only the ability to move many more gigabytes of data than expected with each pass, but also the u8's ability to operate in polar environments, where many of Kepler's early adopters operate. With Kepler's recently increased capacity the u8 can serve customers globally, pole-to-pole and all points in between."

In January, Kepler launched 8 new satellites via SpaceX’s first dedicated SmallSat Rideshare Program. On March 22nd , Kepler launched an additional two satellites via the Soyuz-2, expanding its active constellation to 15 satellites in total. An additional launch is planned for June. Kymeta believes the collaboration with Kepler and further testing is instrumental to providing reliable connectivity and superior benefits to customers.

Kymeta next-generation solutions are built for mobility and designed specifically for the needs of global defense agencies, government, public safety, and commercial customers. Through the launch of the u8 and Kymeta Connect, the company has meaningfully increased antenna throughput and reduced the total cost of ownership. Its products offer a breakthrough in performance, ease of use, and hybrid satellite-cellular connectivity services.

About Kymeta

Kymeta is unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Lepton Global Solutions, a Kymeta company, hosts the company’s satellite connectivity solutions and offers unique, complete, and turnkey bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta Connect™ services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for lightweight, slim, and high-throughput communication systems that do not require mechanical components to steer toward a satellite. Kymeta makes connecting easy – for any vehicle, vessel, or fixed platform.

Kymeta is a privately held company based in Redmond, Washington.

For more information, visit kymetacorp.com .

About Kepler Communications Inc.

Kepler is a satellite telecommunications provider based in Canada, backed by Costanoa Ventures, IA Ventures and other leading investors. Kepler’s mission is to connect people and things Everywhere, on earth and beyond. To this end, Kepler will build an in-space telecommunications network through an incremental deployment of products and technologies. The first to launch and operate a Ku-band satellite service in Low Earth Orbit, Kepler has expanded its capabilities with the successful commissioning of a cubesat production facility at their Toronto headquarters, from which the GEN 1 satellites are being delivered.

For more information, visit www.kepler.space and @KeplerComms.

Link:

ClickThru

Social Media:

https://www.facebook.com/kymetacorp

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye